A phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis DOI
Jingjing Yang, Qingyang Liu, Xiawei Zhang

и другие.

International Immunopharmacology, Год журнала: 2025, Номер 151, С. 114268 - 114268

Опубликована: Фев. 21, 2025

Язык: Английский

Epigenetic regulation of macrophage function in kidney disease: New perspective on the interaction between epigenetics and immune modulation DOI Open Access

Ruizhi Tan,

Qianrong Bai, Lingfei Jia

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2025, Номер 183, С. 117842 - 117842

Опубликована: Янв. 13, 2025

Язык: Английский

Процитировано

0

Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders DOI
Azhagu Madhavan Sivalingam

Clinical Reviews in Allergy & Immunology, Год журнала: 2025, Номер 68(1)

Опубликована: Фев. 11, 2025

Язык: Английский

Процитировано

0

Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways DOI Creative Commons

John Kaszycki,

Minji Kim

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Фев. 19, 2025

The NLRP3 inflammasome and NF-κB signaling pathways play crucial roles in orchestrating inflammation immune defense.​ This review explores the intricate relationship between these epigenetic regulation, a field of growing importance understanding responses. Epigenetic modifications, including DNA methylation, histone non-coding RNAs (ncRNAs), significantly influence activity genes involved pathways, thereby modulating inflammatory provides comprehensive overview current research on how mechanisms interact with regulate pathways. It delves into advanced concepts such as RNA modifications 3D genome organization, their impact regulation. Furthermore, implications findings for developing novel therapeutic strategies targeting regulators diseases are discussed. By synthesizing recent advancements this rapidly evolving field, underscores critical role regulation highlights potential epigenetic-based therapies treating wide range conditions, autoimmune disorders cancer.

Язык: Английский

Процитировано

0

A phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis DOI
Jingjing Yang, Qingyang Liu, Xiawei Zhang

и другие.

International Immunopharmacology, Год журнала: 2025, Номер 151, С. 114268 - 114268

Опубликована: Фев. 21, 2025

Язык: Английский

Процитировано

0